Napredna pretraga

Pregled bibliografske jedinice broj: 734871

Ustekinumab in patients with moderate and severe psoriasis: our experience


Bakija-Konsuo, Ana; Čarija Antoanela
Ustekinumab in patients with moderate and severe psoriasis: our experience // Abstract on CD
Amsterdam, Netherlands, 2014. (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Ustekinumab in patients with moderate and severe psoriasis: our experience

Autori
Bakija-Konsuo, Ana ; Čarija Antoanela

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract on CD / - , 2014

Skup
EADV congress

Mjesto i datum
Amsterdam, Netherlands, 8-12.10.2014

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Psorijaza; ustekinumab; uspojave
(Psoriasis; ustekinumab; side effects)

Sažetak
The aim of this report is to present our experience of ustekinumab in Croatian patients with long-standing, moderate-to-severe plaque psoriasis. We present 9 patients who received ustekinumab 45 or 90 mg at weeks 0 and 4. They have continued treatment every 12 weeks.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Sveučilište u Dubrovniku

Citiraj ovu publikaciju

Bakija-Konsuo, Ana; Čarija Antoanela
Ustekinumab in patients with moderate and severe psoriasis: our experience // Abstract on CD
Amsterdam, Netherlands, 2014. (poster, međunarodna recenzija, sažetak, znanstveni)
Bakija-Konsuo, A. & Čarija Antoanela (2014) Ustekinumab in patients with moderate and severe psoriasis: our experience. U: Abstract on CD.
@article{article, author = {Bakija-Konsuo, A. and \v{C}arija Antoanela}, year = {2014}, keywords = {psoriasis, ustekinumab, side effects}, title = {Ustekinumab in patients with moderate and severe psoriasis: our experience}, keyword = {psoriasis, ustekinumab, side effects}, publisherplace = {Amsterdam, Netherlands} }